All News about Karuna Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/03/22/image22.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230321006020/en/718340/5/Karuna_TX_-_Logo_-_Standard.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/21/image_6.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Karuna Therapeutics's Future
March 21, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230320005664/en/718340/5/Karuna_TX_-_Logo_-_Standard.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/enph1600.jpg)
![](https://investorplace.com/wp-content/uploads/2023/03/ubs-stock-bank-sign-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/20/aapharma_3.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/09/pills-1.jpg)
![](https://www.investors.com/wp-content/uploads/2022/05/Stock-drugsdish-01-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Karuna Therapeutics
March 02, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Looking Into Karuna Therapeutics's Return On Capital Employed
February 28, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/9233e756-baad-4008-8d00-a4d07826f0e3/small/zailab-png.png)
![](https://mms.businesswire.com/media/20230320005250/en/718340/5/Karuna_TX_-_Logo_-_Standard.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_5981.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Karuna Therapeutics's Future
January 27, 2023
Via Benzinga
5 Analysts Have This to Say About Karuna Therapeutics
December 09, 2022
Via Benzinga
What 5 Analyst Ratings Have To Say About Karuna Therapeutics
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/06/image-apple-logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/02/image-target2.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230223005266/en/718340/5/Karuna_TX_-_Logo_-_Standard.jpg)
![](https://mms.businesswire.com/media/20230209005220/en/718340/5/Karuna_TX_-_Logo_-_Standard.jpg)
From Karuna
Via Business Wire
Where Karuna Therapeutics Stands With Analysts
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30579.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Karuna Therapeutics
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/03/krtx_logo_light__5ab4f4e09bf3f82a517f93702cc13b5a.png?width=1200&height=800&fit=crop)
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
February 03, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230202005296/en/718340/5/Karuna_TX_-_Logo_-_Standard.jpg)
![](https://mms.businesswire.com/media/20230131005281/en/718340/5/Karuna_TX_-_Logo_-_Standard.jpg)
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.